Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGG492 interaction study with a monophasic oral contraceptive in healthy women
NL-OMON34415Active, not recruiting
- Sponsor
- Novartis
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of selurampanel in epilepsy (2 arms), sponsored by Novartis. Primary endpoint: Pharmacokinetics of ethinyl estradiol and levonorgestrel on day 14. Started Aug 2010; status: active, not recruiting.
02
Drugs
selurampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON34415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34415.